BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29719806)

  • 1. Daily use of guaifenesin (Mucinex) in a patient with chronic bronchitis and pathologic mucus hypersecretion: A case report.
    Storms WW; Miller JE
    Respir Med Case Rep; 2018; 23():156-157. PubMed ID: 29719806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved quality of life associated with long-term use of guaifenesin in a patient with chronic obstructive pulmonary disease (COPD) & stable chronic bronchitis: A case report.
    Singer E; Miller JE
    Respir Med Case Rep; 2019; 26():9-10. PubMed ID: 30450278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.
    Albrecht HH; Dicpinigaitis PV; Guenin EP
    Multidiscip Respir Med; 2017; 12():31. PubMed ID: 29238574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.
    Ohar JA; Donohue JF; Spangenthal S
    Chronic Obstr Pulm Dis; 2019 Oct; 6(4):341-9. PubMed ID: 31647856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved lung function and quality of life following guaifenesin treatment in a patient with chronic obstructive pulmonary disease (COPD): A case report.
    Storms WW; Miller JE
    Respir Med Case Rep; 2018; 24():84-85. PubMed ID: 29977767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved quality of life associated with long-term daily use of guaifenesin (Mucinex
    Singer E; Miller JE
    Oxf Med Case Reports; 2018 Sep; 2018(9):omy060. PubMed ID: 30159154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection.
    Tripathi S; Nikhare A; Sharma G; Shea T; Albrecht H
    Drug Healthc Patient Saf; 2019; 11():87-94. PubMed ID: 31632154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
    Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
    Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol.
    Rubin BK
    Chest; 1999 Jul; 116(1):195-200. PubMed ID: 10424525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful long-term, adjunctive use of guaifenesin in a patient with a complex atopic medical history and primary immune deficiency: A case report.
    Lanier BQ; Miller J
    Respir Med Case Rep; 2018; 25():145-146. PubMed ID: 30175035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiotropium ameliorates symptoms in patients with chronic airway mucus hypersecretion which is resistant to macrolide therapy.
    Saito Y; Azuma A; Morimoto T; Fujita K; Abe S; Motegi T; Usuki J; Kudoh S
    Intern Med; 2008; 47(7):585-91. PubMed ID: 18379141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total population study of factors affecting chronic bronchitis prevalence in the coal mining industry of New South Wales, Australia.
    Leigh J; Wiles AN; Glick M
    Br J Ind Med; 1986 Apr; 43(4):263-71. PubMed ID: 3964575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy.
    Jeyakumar A; Brickman TM; Haben M
    Laryngoscope; 2006 Dec; 116(12):2108-12. PubMed ID: 17146380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
    Del Donno M; Olivieri D
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
    Martínez-Rivera C; Crespo A; Pinedo-Sierra C; García-Rivero JL; Pallarés-Sanmartín A; Marina-Malanda N; Pascual-Erquicia S; Padilla A; Mayoralas-Alises S; Plaza V; López-Viña A; Picado C
    Respir Med; 2018 Feb; 135():22-28. PubMed ID: 29414449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In brief: Mucinex.
    Med Lett Drugs Ther; 2005 Feb; 47(1202):16. PubMed ID: 15711500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DOUBLE BLIND CLINICAL EVALUATION OF GLYCERYL GUAIACOLATE.
    TOWNLEY RG; BRONSTEIN SB
    Ann Allergy; 1963 Dec; 21():683-91. PubMed ID: 14085798
    [No Abstract]   [Full Text] [Related]  

  • 18. Reassessment of inflammation of airways in chronic bronchitis.
    Mullen JB; Wright JL; Wiggs BR; Pare PD; Hogg JC
    Br Med J (Clin Res Ed); 1985 Nov; 291(6504):1235-9. PubMed ID: 3933614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections.
    Hoffer-Schaefer A; Rozycki HJ; Yopp MA; Rubin BK
    Respir Care; 2014 May; 59(5):631-6. PubMed ID: 24003241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study of the effect of guaiphenesin on mucociliary clearance from the human lung.
    Thomson ML; Pavia D; McNicol MW
    Thorax; 1973 Nov; 28(6):742-7. PubMed ID: 4595814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.